Status:

COMPLETED

Efficacy and Systemic Safety of Netarsudil 0.01%, 0.02%, 0.04% Relative to Placebo in Subjects With Open-angle Glaucoma or Ocular Hypertension in Japan

Lead Sponsor:

Aerie Pharmaceuticals

Conditions:

Open Angle Glaucoma

Ocular Hypertension

Eligibility:

All Genders

20+ years

Phase:

PHASE2

Brief Summary

Test ocular hypotensive efficacy and systemic safety of netarsudil 0.01%, 0.02%, 0.04% relative to placebo in subjects with open-angle glaucoma or ocular hypertension in Japan

Eligibility Criteria

Inclusion

  • Must be 20 years of age or older
  • Diagnosis of open-angle glaucoma (OAG) or ocular hypertension (OHT) in both eyes. (OAG in one eye and OHT in the fellow eye is acceptable)
  • BCVA 0.1 or better in decimal unit using Landolt-C chart or its equivalent
  • Able and willing to give signed informed consent and following study instructions

Exclusion

  • Clinically significant ocular diseases
  • Pseudoexfoliation or pigment dispersion component glaucoma, history of narrow angle closure glaucoma or narrow angles
  • Previous glaucoma intraocular surgery
  • Refractive surgery in either eye
  • Ocular trauma
  • Ocular infection or inflammation
  • Known hypersensitivity to benzalkonium chloride or excipient of netarsudil ophthalmic solution
  • Cannot demonstrate proper delivery of the eye drop
  • Clinically significant abnormalities in screen lab tests
  • Clinically significant systemic disease
  • Participation in any investigational study within 30 days of screening
  • Women of child-bearing potential who are pregnant, nursing, planning a pregnancy or not using a medically acceptable form of birth control

Key Trial Info

Start Date :

March 19 2019

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

September 19 2019

Estimated Enrollment :

215 Patients enrolled

Trial Details

Trial ID

NCT03844945

Start Date

March 19 2019

End Date

September 19 2019

Last Update

October 19 2020

Active Locations (25)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 7 (25 locations)

1

Nomura Eye Clinic

Ichinomiya-shi, Aichi-ken, Japan

2

Shisui ophthalmology clinic

Shisui, Chiba, Japan

3

Nakamori Eye Clinic

Kitakyushu-shi, Fukuoka, Japan

4

Southern TOHOKU Eye Clinic

Koriyama-shi, Fukushima, Japan